Unknown PHASE4 INTERVENTIONAL 2-arm NCT01053377

A Randomised Controlled Trial on the Effect of Post-exposure Oseltamivir Prophylaxis on Influenza Transmission in Nursing Homes (PEPpIE)

Sponsor: National Institute for Public Health and the Environment (RIVM)

Conditions Influenza

Interventions Tamiflu (verum) Tamiflu placebo

Updated 6 times since 2017 Last updated: Jan 20, 2010 Started: Dec 31, 2009 Primary completion: Dec 31, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01053377, this PHASE4 trial focuses on Influenza and remains ongoing. Sponsored by National Institute for Public Health and the Environment (RIVM), it has been updated 6 times since 2009, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

Status: Enrolling By Invitation → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Enrolling By Invitation PHASE4

First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute for Public Health and the Environment (RIVM)
ZonMw: The Netherlands Organisation for Health Research and Development

Data source: National Institute for Public Health and the Environment (RIVM)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bilthoven, Netherlands